Gain Therapeutics, Inc. - Common Stock (NQ:GANX)
1.710
-0.030
(-1.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 15, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 214,692 |
| Open | 1.740 |
| Bid (Size) | 1.710 (100) |
| Ask (Size) | 1.770 (300) |
| Prev. Close | 1.740 |
| Today's Range | 1.690 - 1.740 |
| 52wk Range | 1.530 - 4.340 |
| Shares Outstanding | 27,132,588 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Which stocks are moving on Wednesday? ↗
March 18, 2026
Keep an eye on the top gainers and losers in Thursday's session. ↗
December 18, 2025
There are notable gap-ups and gap-downs in today's session. ↗
December 18, 2025
Frequently Asked Questions
Is Gain Therapeutics, Inc. - Common Stock publicly traded?
Yes, Gain Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Gain Therapeutics, Inc. - Common Stock trade on?
Gain Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gain Therapeutics, Inc. - Common Stock?
The ticker symbol for Gain Therapeutics, Inc. - Common Stock is GANX on the Nasdaq Stock Market
What is the current price of Gain Therapeutics, Inc. - Common Stock?
The current price of Gain Therapeutics, Inc. - Common Stock is 1.710
When was Gain Therapeutics, Inc. - Common Stock last traded?
The last trade of Gain Therapeutics, Inc. - Common Stock was at 09/15/26 04:00 PM ET
What is the market capitalization of Gain Therapeutics, Inc. - Common Stock?
The market capitalization of Gain Therapeutics, Inc. - Common Stock is 46.40M
How many shares of Gain Therapeutics, Inc. - Common Stock are outstanding?
Gain Therapeutics, Inc. - Common Stock has 46M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
